Evaluation of Hematological and Biochemical Parameters that Predict the No-reflow Phenomenon in Patients Undergoing Primary Percutaneous Coronary Intervention

被引:0
|
作者
Aydemir, Selim [1 ]
Aydin, Sidar Siyar [2 ]
Altinkaya, Onur [1 ]
Aksakal, Emrah [1 ]
Ozmen, Murat [1 ]
机构
[1] Univ Hlth Sci, Erzurum City Hosp, Dept Cardiol, TR-25080 Erzurum, Turkiye
[2] Ataturk Univ, Fac Med, Dept Cardiol, Erzurum, Turkiye
关键词
acute coronary syndrome; no-reflow phenomenon; primary percutaneous coronary intervention; ELEVATION MYOCARDIAL-INFARCTION; TO-LYMPHOCYTE RATIO; CELL DISTRIBUTION WIDTH; ADVERSE CARDIAC EVENTS; LONG-TERM OUTCOMES; MICROVASCULAR OBSTRUCTION; NEUTROPHIL/LYMPHOCYTE RATIO; D-DIMER; NEUTROPHIL; MORTALITY;
D O I
10.1177/00033197251320141
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Acute coronary syndromes (ACS) are one of the most common causes of morbidity and mortality worldwide. Primary percutaneous coronary intervention (pPCI) is the main treatment strategy to restore myocardial perfusion. However, the no-reflow phenomenon (NRP) may block coronary flow. The present study focused on assessing and contrasting predictive parameters for NRP in ACS patients. Our research is a retrospective analysis. We assessed the parameters significantly associated with NRP using Cox regression and Receiver operating characteristic (ROC) Curve analysis. The study included 5122 patients who met the criteria. The average age of the patients was 63.9 + 13.2, and 74.4% were male. It was observed that NRP developed in 1.8% of all patients. Age, hemoglobin (Hb), white blood cell (WBC), glucose and low density lipoprotein cholesterol (LDL-C) were determined to be independent predictors of NRP. The power of these parameters to predict NRP was similar, and WBC was the most predictive (Area Under Curve (AUC): 0.605 95% CI: 0.539-0.671, P = .001). We believe that the use of these simple, practical, and routinely used hematological and biochemical parameters will help us predict the risk of developing NRP before pPCI. This information should improve management.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Vitamin D deficiency predicts the no-reflow phenomenon in STEMI patients undergoing primary percutaneous coronary intervention
    Verdoia, M.
    Gioscia, R.
    Viglione, F.
    Rolla, R.
    Viola, O.
    Brancati, M. F.
    Solda', P. L.
    Marcolongo, M.
    De Luca, G.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2155 - 2155
  • [2] Role of Intracoronary Adrenaline in the Treatment of No-Reflow Phenomenon in Patients Undergoing Percutaneous Coronary Intervention
    Simoni, Leonard
    Gjana, Armand
    Ziu, Kristi
    Dibra, Alban
    Goda, Artan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [3] Prognosis of no-reflow phenomenon in patients after percutaneous coronary intervention
    Cong, HL
    Du, JB
    Zhang, M
    Wang, W
    Xu, Y
    Chen, XT
    Li, GP
    Huang, TG
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (8A): : 55A - 55A
  • [4] Utility of Hematological Parameters in Predicting No-Reflow Phenomenon After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction
    Wang, Zuoyan
    Ren, Lihui
    Liu, Na
    Peng, Jianjun
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2018, 24 (07) : 1177 - 1183
  • [5] Utility of electrocardiogram to predict the occurrence of the no-reflow phenomenon in patients undergoing primary percutaneous coronary intervention (PPCI): a systematic review and meta-analysis
    Afshar, Elmira Jafari
    Gholami, Niloofar
    Samimisedeh, Parham
    Mozafarybazargany, Mohammadhossein
    Tayebi, Amirhossein
    Memari, Amirhossein
    Yazdani, Shahrooz
    Rastad, Hadith
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 10
  • [6] Impact of Stress Hyperglycemia on No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
    Khalfallah, Mohamed
    Maria, Dina A.
    Allaithy, Amany
    GLOBAL HEART, 2022, 17 (01)
  • [7] Predictors of No-Reflow Phenomenon in Tunisian Patients Undergoing Primary Percutaneous Coronary Intervention for St-Elevation Myocardial Infarction
    Jomaa, Walid
    Jnifene, Zouhair
    Chamtouri, Ikram
    Ben Hamda, Khaldoun
    Maatouk, Faouzi
    JACC-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (04) : S9 - S9
  • [8] Prediction of platelet distribution width on no-reflow phenomenon in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
    Wang, Yanbo
    Fu, Xianghua
    Wang, Xuechao
    Gu, Xinshun
    Zhao, Yujun
    CIRCULATION, 2012, 125 (19) : E856 - E856
  • [9] Predictors of no-reflow in patients undergoing primary percutaneous coronary intervention. Thrombus aspiration was protective
    Hassan, Ayman K. M.
    Mohamed, Hamdy Shams Eddin
    Mohamed, Ahmed Mahdy
    Ahmed, Tarek A. N.
    Kishk, Yehia Taha
    EGYPTIAN HEART JOURNAL, 2018, 70 (04): : 421 - 426
  • [10] A score system to predict no-reflow in primary percutaneous coronary intervention: The PIANO Score
    Dai, Chunfeng
    Liu, Muyin
    Zhou, You
    Lu, Danbo
    Li, Chenguang
    Chang, Shufu
    Chen, Zhangwei
    Qian, Juying
    Ge, Junbo
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2022, 52 (02)